Not sure this will have to go through phase 1, 2, 3 like a pharma does?
Currently proof of concept - done - and it works. They would likely be able to go straight into a larger confirmation trial.
BTM was able to get TGA and a FDA 510k approval after a free flap donor site trial and a 5 person large TBSA burn trial (obviously with many animal trials prior to these).
Ann: BTM delivers positive First in Man results in Cell Therapies, page-71
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
0.020(1.69%) |
Mkt cap ! $832.4M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.23 | $1.17 | $2.070M | 1.719M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24841 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 21540 | 3 |
View Market Depth
| Last trade - 16.18pm 24/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |